NEOG — NEOGEN CORP
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 711377 ·
Last close
$10.90
Market Cap
$2.38B
52W High
$14.26
52W Low
$5.37
ADV30
3,452,170
Next earnings
2027-01-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Aug 2026 | 222,800,000 | 105,500,000 | -1,800,000 | -11,900,000 | 3,303,200,000 | 172,000,000 | 1,216,800,000 |
| May 2026 | 225,300,000 | 107,800,000 | 3,100,000 | -11,300,000 | 3,346,000,000 | 185,500,000 | 1,253,100,000 |
| Feb 2026 | 211,200,000 | 99,000,000 | -3,300,000 | -17,000,000 | 3,359,000,000 | 159,900,000 | 1,256,600,000 |
| Nov 2025 | 224,691,000 | 106,684,000 | -5,377,000 | -15,924,000 | 3,359,953,000 | 145,340,000 | 1,255,465,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$83,200,000
Investing CF
$70,500,000
Financing CF
$-99,400,000
CapEx
$-51,300,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-10-17
Balance + Analyst (yfinance extras)
Retained Earnings
$-544,300,000
Inventory
$144,300,000
Receivables
$146,800,000
ST Investments
$0
EBIT TTM
$50,134,000
Pretax Income TTM
$-8,956,000
Interest Exp TTM
$59,090,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$884,000,000
EBITDA
$109,000,000
Free Cash Flow
$38,936,000
Enterprise Value
$3,180,494,336
Total Cash
$172,000,000
Total Debt
$774,300,032
Shares Out
218,306,034
Trailing EPS
$-0.26
Book Value
$9.56
ROE
-2.7%
ROA
-0.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| May 2026 | 870,400,000 | -21,600,000 | -7,900,000 | 3,346,000,000 | 1,253,100,000 | 2,092,900,000 | 83,200,000 |
| May 2025 | 894,700,000 | -1,700,000 | -1,092,000,000 | 3,443,800,000 | 1,372,600,000 | 2,071,200,000 | 58,200,000 |
| May 2024 | 924,200,000 | 58,600,000 | -9,400,000 | 4,548,833,000 | 1,404,691,000 | 3,144,142,000 | 35,300,000 |
| May 2023 | 822,447,000 | 37,515,000 | -22,870,000 | 4,554,432,000 | 1,420,215,000 | 3,134,217,000 | 41,028,000 |
TTM Snapshot
Revenues TTM
$870,400,000
NetIncome TTM
$-7,900,000
OpCashFlow TTM
—
Assets (Latest)
$3,359,000,000
Forward EPS
$0.40
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $11.08 · call volume: 5,005 · put volume: 5,040
Expected Move to 2027-04-16:
±$2.82
(25.45%) —
implied range
$8.26 –
$13.90
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | $2.20B | $28.04 | — |
| NTLA | Intellia Therapeutics, Inc. | $1.37B | $9.78 | — |
| ABSI | Absci Corp | $1.31B | $7.58 | — |
| LNTH | Lantheus Holdings, Inc. | $6.66B | $101.80 | — |
| OABI | OmniAb, Inc. | $736.59M | $5.05 | — |
News headlines (Yahoo Finance, 1h cache)
Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?
2026-11-05 15:30 · Yahoo
3 Reasons to sell NEOG and 1 stock to buy instead
2026-10-24 00:32 · Yahoo
NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
2026-10-20 15:36 · Yahoo
NEOG Q3 Deep Dive: Commercial Execution, Innovation, and Operational Progress Shape Outlook
2026-10-19 15:44 · Yahoo
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
2026-10-12 11:55 · Yahoo
Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product
2026-10-08 16:19 · Yahoo
The 5 Most Interesting Analyst Questions From Neogen’s Q3 Earnings Call
2026-10-08 07:20 · Yahoo
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
2026-10-08 02:02 · Yahoo
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
2026-10-07 22:33 · Yahoo
Why Are Neogen (NEOG) Shares Soaring Today
2026-10-07 18:56 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.